These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 18295974)

  • 1. The cDNA 385C to A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) is associated with overweight/obesity but not with binge eating disorder in overweight/obese women.
    Monteleone P; Tortorella A; Martiadis V; Di Filippo C; Canestrelli B; Maj M
    Psychoneuroendocrinology; 2008 May; 33(4):546-50. PubMed ID: 18295974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of CNR1 and FAAH endocannabinoid gene polymorphisms with anorexia nervosa and bulimia nervosa: evidence for synergistic effects.
    Monteleone P; Bifulco M; Di Filippo C; Gazzerro P; Canestrelli B; Monteleone F; Proto MC; Di Genio M; Grimaldi C; Maj M
    Genes Brain Behav; 2009 Oct; 8(7):728-32. PubMed ID: 19659925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of 3111T/C polymorphism of the CLOCK gene in obese individuals with or without binge eating disorder: association with higher body mass index.
    Monteleone P; Tortorella A; Docimo L; Maldonato MN; Canestrelli B; De Luca L; Maj M
    Neurosci Lett; 2008 Apr; 435(1):30-3. PubMed ID: 18314271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C358A missense polymorphism of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) and visfatin levels in obese females.
    de Luis DA; Gonzalez Sagrado M; Aller R; Izaola O; Conde R; Romero E
    Int J Obes (Lond); 2010 Mar; 34(3):511-5. PubMed ID: 20065978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [C358A polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) and adipocytokine levels in the morbidly obese].
    De Luis DA; González Sagrado M; Aller R; Izaola O; Conde R; Romero E
    Endocrinol Nutr; 2010 Feb; 57(2):54-9. PubMed ID: 20189896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocannabinoid Pro129Thr FAAH functional polymorphism but not 1359G/A CNR1 polymorphism is associated with antipsychotic-induced weight gain.
    Monteleone P; Milano W; Petrella C; Canestrelli B; Maj M
    J Clin Psychopharmacol; 2010 Aug; 30(4):441-5. PubMed ID: 20631561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of C358A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase on weight loss after a hypocaloric diet.
    de Luis DA; Gonzalez Sagrado M; Aller R; Izaola O; Conde R
    Metabolism; 2011 May; 60(5):730-4. PubMed ID: 20716455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association study between alcoholism and endocannabinoid metabolic enzyme genes encoding fatty acid amide hydrolase and monoglyceride lipase in a Japanese population.
    Iwasaki S; Ishiguro H; Higuchi S; Onaivi ES; Arinami T
    Psychiatr Genet; 2007 Aug; 17(4):215-20. PubMed ID: 17621164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating ghrelin is decreased in non-obese and obese women with binge eating disorder as well as in obese non-binge eating women, but not in patients with bulimia nervosa.
    Monteleone P; Fabrazzo M; Tortorella A; Martiadis V; Serritella C; Maj M
    Psychoneuroendocrinology; 2005 Apr; 30(3):243-50. PubMed ID: 15511598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A nonsynonymous polymorphism in the human fatty acid amide hydrolase gene did not associate with either methamphetamine dependence or schizophrenia.
    Morita Y; Ujike H; Tanaka Y; Uchida N; Nomura A; Ohtani K; Kishimoto M; Morio A; Imamura T; Sakai A; Inada T; Harano M; Komiyama T; Yamada M; Sekine Y; Iwata N; Iyo M; Sora I; Ozaki N; Kuroda S
    Neurosci Lett; 2005 Mar; 376(3):182-7. PubMed ID: 15721218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The fatty acid amide hydrolase (FAAH) Pro129Thr polymorphism is not associated with severe obesity in Greek subjects.
    Papazoglou D; Panagopoulos I; Papanas N; Gioka T; Papadopoulos T; Papathanasiou P; Kaitozis O; Papatheodorou K; Maltezos E
    Horm Metab Res; 2008 Dec; 40(12):907-10. PubMed ID: 18819056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of the fatty acid amide hydrolase 385C>A single nucleotide polymorphisms on obesity susceptibility.
    Yagin NL; Aliasgari F; Aliasgharzadeh S; Mahdavi R; Akbarzadeh M
    Mol Biol Rep; 2019 Oct; 46(5):5049-5055. PubMed ID: 31286394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variation in endocannabinoid metabolism, gastrointestinal motility, and sensation.
    Camilleri M; Carlson P; McKinzie S; Grudell A; Busciglio I; Burton D; Baxter K; Ryks M; Zinsmeister AR
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G13-9. PubMed ID: 17962356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binge-eating disorder as a distinct familial phenotype in obese individuals.
    Hudson JI; Lalonde JK; Berry JM; Pindyck LJ; Bulik CM; Crow SJ; McElroy SL; Laird NM; Tsuang MT; Walsh BT; Rosenthal NR; Pope HG
    Arch Gen Psychiatry; 2006 Mar; 63(3):313-9. PubMed ID: 16520437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of endocannabinoids levels, FAAH gene polymorphisms, and appetite regulatory substances in women with and without binge eating disorder: a cross- sectional study.
    Yagin NL; Aliasgari F; Alizadeh M; Aliasgharzadeh S; Mahdavi R
    Nutr Res; 2020 Nov; 83():86-93. PubMed ID: 33038759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of fatty acid hydrolase gene variants in inflammatory bowel disease.
    Storr M; Emmerdinger D; Diegelmann J; Yüce B; Pfennig S; Ochsenkühn T; Göke B; Lohse P; Brand S
    Aliment Pharmacol Ther; 2009 Mar; 29(5):542-51. PubMed ID: 19053981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating Endocannabinoids and the Polymorphism 385C>A in Fatty Acid Amide Hydrolase (FAAH) Gene May Identify the Obesity Phenotype Related to Cardiometabolic Risk: A Study Conducted in a Brazilian Population of Complex Interethnic Admixture.
    Martins CJ; Genelhu V; Pimentel MM; Celoria BM; Mangia RF; Aveta T; Silvestri C; Di Marzo V; Francischetti EA
    PLoS One; 2015; 10(11):e0142728. PubMed ID: 26561012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating levels of neuroactive steroids in patients with binge eating disorder: a comparison with nonobese healthy controls and non-binge eating obese subjects.
    Monteleone P; Luisi M; De Filippis G; Colurcio B; Monteleone P; Genazzani AR; Maj M
    Int J Eat Disord; 2003 Dec; 34(4):432-40. PubMed ID: 14566930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depression.
    Monteleone P; Bifulco M; Maina G; Tortorella A; Gazzerro P; Proto MC; Di Filippo C; Monteleone F; Canestrelli B; Buonerba G; Bogetto F; Maj M
    Pharmacol Res; 2010 May; 61(5):400-4. PubMed ID: 20080186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine for "wanting" and opioids for "liking": a comparison of obese adults with and without binge eating.
    Davis CA; Levitan RD; Reid C; Carter JC; Kaplan AS; Patte KA; King N; Curtis C; Kennedy JL
    Obesity (Silver Spring); 2009 Jun; 17(6):1220-5. PubMed ID: 19282821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.